▶ 調査レポート

膣用抗真菌薬のグローバル市場

• 英文タイトル:Global Market Study on Vaginal Antifungals: Around One-third Market Share Accounted for by Clotrimazole Drugs

Global Market Study on Vaginal Antifungals: Around One-third Market Share Accounted for by Clotrimazole Drugs「膣用抗真菌薬のグローバル市場」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2304I0189
• 出版社/出版日:Persistence Market Research / 2023年1月30日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Site Licence¥1,140,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,590,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、世界の膣用抗真菌薬市場にフォーカスし、最新動向と今後の市場性について分析しています。本書は、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症危機分析、需要分析・予測、治療薬別(フルコナゾール、ナイスタチン、フルシトシン、クロトリマゾール、その他)分析、投与経路別(経口、局所)分析、流通チャネル別(病院薬局、小売薬局、オンライン薬局)分析、地域別(北米、中南米、ヨーロッパ、東アジア、南アジア、オセアニア、中東・アフリカ)分析、市場構造分析、競争分析、仮定、調査手法などの情報を整理しています。また、Pfizer Inc.、Bausch Health Companies Inc、ANI Pharmaceuticals, Inc.、Hikma Pharmaceuticals Plc、Lupin Limited、Mycovia Pharmaceuticals, Inc.、Glenmark Pharmaceuticals Limited、Unique Pharmaceuticals、PEPTONIC medical AB、Aurobindo Pharma Limited、Dr. Reddy's Laboratories、SCYNEXIS, Inc.、Basilea Pharmaceutica Ltd.、Astellas Pharma Inc.など、主要企業情報が含まれています。

・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・市場背景
・新型コロナウイルス感染症危機分析
・需要分析・予測
・世界の膣用抗真菌薬市場規模:治療薬別
- フルコナゾールの市場規模
- ナイスタチンの市場規模
- フルシトシンの市場規模
- クロトリマゾールの市場規模
- その他治療薬の市場規模
・世界の膣用抗真菌薬市場規模:投与経路別
- 経口投与における市場規模
- 局所投与における市場規模
・世界の膣用抗真菌薬市場規模:流通チャネル別
- 病院薬局チャネルの市場規模
- 小売薬局チャネルの市場規模
- オンライン薬局チャネルの市場規模
・世界の膣用抗真菌薬市場規模:地域別
- 北米の膣用抗真菌薬市場規模
- 中南米の膣用抗真菌薬市場規模
- ヨーロッパの膣用抗真菌薬市場規模
- 東アジアの膣用抗真菌薬市場規模
- 南アジアの膣用抗真菌薬市場規模
- オセアニアの膣用抗真菌薬市場規模
- 中東・アフリカの膣用抗真菌薬市場規模
・市場構造分析
・競争分析
・仮定
・調査手法

Vaginal Antifungals Market – Report Scope

A recent market study published by Persistence Market Research on the vaginal antifungals market offers a global industry analysis for 2017 to 2021 and an opportunity assessment for 2022 to 2032. The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the vaginal antifungals market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the vaginal antifungals market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.

The report provides detailed information about the current and future growth prospects of the vaginal antifungals market in the most comprehensive way for a better understanding of readers.

Key Market Segments

The study on the vaginal antifungals market offers insights divided into four important segments – drug, route of administration, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug
Fluconazole
Nystatin
Flucytosine
Clotrimazole
Ketoconazole
Terbinafine
Others

Route of Administration
Oral
Topical

Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa

Chapter 1 – Executive Summary

The report commences with the executive summary of the vaginal antifungals market report, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the vaginal antifungals market as well as the key trends influencing the market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and drug definition/scope /limitations and inclusions and exclusions of the vaginal antifungals market in this chapter, which helps the readers to understand basic information about the vaginal antifungals market.

Chapter 3 – Key Market Trends

This section highlights the key trends influencing the vaginal antifungals market, which will help readers in understanding the current trends and their impact on market growth.

Chapter 4 – Key Success Factors

This section highlights the market context impacting the vaginal antifungals market, which will help readers in understanding promotional strategies, by key manufacturers, key regulations, reimbursement scenario, pipeline analysis, value chain analysis, PESTEL analysis, and Porter’s analysis, that are expected to create a positive impact on the growth of the vaginal antifungals market during the forecast period.

Chapter 5- Market Background

This chapter explains the key macroeconomic factors that are expected to influence the growth of the vaginal antifungals market during the forecast period. The chapter also highlights the major forecast factors that will shape market growth. Besides, it provides key dynamics of the vaginal antifungals market, which include the drivers, restraints, and opportunity analysis.

Chapter 6 – COVID-19 Crisis Analysis

This section provides the current and expected impact of COVID-19 on the vaginal antifungals market.

Chapter 7- Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

This section explains the global market value or size analysis and forecasts for the vaginal antifungals market during the forecast period. Along with the historical market and opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2022), and an incremental $ opportunity for the forecast period (2022–2032).

Chapter 8- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, by Drug

Based on the drug, the vaginal antifungals market is segmented into Fluconazole, Nystatin, Flucytosine, Clotrimazole, Ketoconazole, Terbinafine, and others. In this chapter, readers can find information about a detailed analysis of the market by different drugs available in the vaginal antifungals market and their growth over the forecast period.

Chapter 9- Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Route of Administration

Based on the route of administration, the vaginal antifungals market is segmented into oral, and topical. In this chapter, readers can find information about a detailed analysis of the market by various routes of administration available in the vaginal antifungals market and their growth over the forecast period.

Chapter 10– Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

Based on the distribution channel, the vaginal antifungals market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. In this chapter, readers can find information about a detailed analysis of the market by distribution channels available in the vaginal antifungals market and their growth over the forecast period.

Chapter 11 – Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032, by Region

This chapter explains how the vaginal antifungals market will grow across seven geographic regions, North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa (MEA).

Chapter 12- North America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes a detailed analysis of the growth of the North American vaginal antifungals market along with a country-wise assessment including the U.S. and Canada. Readers can also find key takeaways of this region, and market growth based on drug, distribution channel, route of administration, and country of the vaginal antifungals market in the North American region.

Chapter 13- Latin America Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes the growth prospects of the vaginal antifungals market in leading countries such as Brazil, Mexico, Argentina, and the rest of Latin America. Readers can find thorough information about the growth parameters based on drug, distribution channel, route of administration, and country in the Latin America vaginal antifungals market during 2022-2032.

Chapter 14- Europe Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter includes the growth prospects of the vaginal antifungals market based on the development of the new product, regulatory approvals, and country in several European countries such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and the Rest of Europe are included in this chapter.

Chapter 15- East Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

China, Japan, and South Korea are the prime subjects of assessment to obtain the growth prospects of the East Asia vaginal antifungals market. In addition, in this chapter, readers can find thorough information about the growth parameters of the East Asia vaginal antifungals market through 2032.

Chapter 16- South Asia Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

India, Thailand, Indonesia, Malaysia, and the rest of South Asia are the prime subjects of assessment to obtain the growth prospects of the vaginal antifungals market. In addition, in this chapter, readers can find thorough information about the growth parameters of the South Asia vaginal antifungals market growth over the forecast period.

Chapter 17- Oceania Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter consists of important parameters that have a huge impact on the growth of the vaginal antifungals market in Oceania, based on market segmentation, during the forecast period. The chapter also provides an overview of the drivers, restraints, and trends in the Oceania vaginal antifungals market.

Chapter 18- Middle East and Africa Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022-2032

This chapter provides information on how the vaginal antifungals market will grow in the major countries in the MEA region, such as GCC Countries, Türkiye, and the rest of MEA during 2022-2032.

Chapter 19- Market Structure Analysis

This chapter highlights the tier structure analysis, market concentration analysis and company share analysis along with sales footprint analysis of key players operating in the vaginal antifungals market.

Chapter 20- Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the vaginal antifungals market including company overview, revenue shares, strategic overview, and recent company developments. Some of the major market players featured in the report are Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Inc., Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Inc., Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals, PEPTONIC Medical AB, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories, SCYNEXIS, Inc., Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., and Amplyx Pharmaceuticals Inc.

Chapter 21 – Assumptions and Acronyms Used

This chapter includes a list of acronyms and assumptions that provide a base for the information and statistics included in the report.

Chapter 22 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the vaginal antifungals market.

レポート目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Key Innovation / Development Trends

4. Key Success Factors

    4.1. Promotional Strategies, By Key Manufacturers

    4.2. Key Regulations

    4.3. Reimbursement Scenario

    4.4. Pipeline Analysis

    4.5. Value Chain Analysis

    4.6. PESTEL Analysis

    4.7. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Expenditure Outlook

        5.1.3. Global Antifungal Drugs Market Outlook

    5.2. Forecast Factors – Relevance & Impact

        5.2.1. Impact of the COVID-19 Pandemic

        5.2.2. Increasing Product Launch Activities

        5.2.3. Prevalence of Vaginal Fungal Infections in HRT Patients

        5.2.4. High Rates of Vulvovaginal Candidiasis

        5.2.5. Impact on Quality-of-Life

        5.2.6. Increasing Number of People with Predisposing Conditions Such as Diabetes Treated with SGLT2 Inhibitors

        5.2.7. Growing Problems of Azole Resistance

        5.2.8. Toxicity of Antifungal Drugs

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Drug

        6.1.2. By Route of Administration

        6.1.3. By Distribution Channel

        6.1.4. By Country

    6.2. 2021 Market Scenario

7. Global Vaginal Antifungals Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022–2032, By Drug

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Drug, 2017 – 2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug, 2022 – 2032

        8.3.1. Fluconazole

        8.3.2. Nystatin

        8.3.3. Flucytosine

        8.3.4. Clotrimazole

        8.3.5. Ketoconazole

        8.3.6. Terbinafine

        8.3.7. Others

    8.4. Market Attractiveness Analysis By Drug

9. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022–2032, By Route of Administration

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2017 – 2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 – 2032

        9.3.1. Oral

        9.3.2. Topical

    9.4. Market Attractiveness Analysis By Route of Administration

10. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022–2032, By Distribution Channel

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2017 – 2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2032

        10.3.1. Hospital Pharmacies

        10.3.2. Retail Pharmacies

        10.3.3. Online Pharmacies

    10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Vaginal Antifungals Market Analysis 2017-2021 and Forecast 2022–2032, By Region

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis By Region

12. North America Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    12.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Drug

        12.3.3. By Route of Administration

        12.3.4. By Distribution Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Drug

        12.4.3. By Route of Administration

        12.4.4. By Distribution Channel

    12.5. Market Trends

    12.6. Key Market Participants – Intensity Mapping

    12.7. Drivers and Restraints – Impact Analysis

    12.8. Country Level Analysis & Forecast

        12.8.1. U.S. Vaginal Antifungals Market Analysis

            12.8.1.1. Introduction

            12.8.1.2. Market Analysis and Forecast By Market Taxonomy

                12.8.1.2.1. By Drug

                12.8.1.2.2. By Route of Administration

                12.8.1.2.3. By Distribution Channel

        12.8.2. Canada Vaginal Antifungals Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast By Market Taxonomy

                12.8.2.2.1. By Drug

                12.8.2.2.2. By Route of Administration

                12.8.2.2.3. By Distribution Channel

13. Latin America Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        13.3.1. By Country

            13.3.1.1. Mexico

            13.3.1.2. Brazil

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

                13.3.1.4.1. By Country

                13.3.1.4.2. By Drug

                13.3.1.4.3. By Route of Administration

                13.3.1.4.4. By Distribution Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Drug

        13.4.3. By Route of Administration

        13.4.4. By Distribution Channel

    13.5. Market Trends

    13.6. Key Market Participants – Intensity Mapping

    13.7. Drivers and Restraints – Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. Mexico Vaginal Antifungals Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast By Market Taxonomy

                13.8.1.2.1. By Drug

                13.8.1.2.2. By Route of Administration

                13.8.1.2.3. By Distribution Channel

        13.8.2. Brazil Vaginal Antifungals Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast By Market Taxonomy

                13.8.2.2.1. By Country

                13.8.2.2.2. By Drug

                13.8.2.2.3. By Route of Administration

                13.8.2.2.4. By Distribution Channel

        13.8.3. Argentina Vaginal Antifungals Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast By Market Taxonomy

                13.8.3.2.1. By Drug

                13.8.3.2.2. By Route of Administration

                13.8.3.2.3. By Distribution Channel

14. Europe Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Drug

        14.3.3. By Route of Administration

        14.3.4. By Distribution Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Drug

        14.4.3. By Route of Administration

        14.4.4. By Distribution Channel

    14.5. Market Trends

    14.6. Key Market Participants – Intensity Mapping

    14.7. Drivers and Restraints – Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. Germany Vaginal Antifungals Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast By Market Taxonomy

                14.8.1.2.1. By Drug

                14.8.1.2.2. By Route of Administration

                14.8.1.2.3. By Distribution Channel

        14.8.2. Italy Vaginal Antifungals Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast By Market Taxonomy

                14.8.2.2.1. By Drug

                14.8.2.2.2. By Route of Administration

                14.8.2.2.3. By Distribution Channel

        14.8.3. France Vaginal Antifungals Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast By Market Taxonomy

                14.8.3.2.1. By Drug

                14.8.3.2.2. By Route of Administration

                14.8.3.2.3. By Distribution Channel

        14.8.4. U.K. Vaginal Antifungals Market Analysis

            14.8.4.1. Introduction

            14.8.4.2. Market Analysis and Forecast By Market Taxonomy

                14.8.4.2.1. By Drug

                14.8.4.2.2. By Route of Administration

                14.8.4.2.3. By Distribution Channel

        14.8.5. Spain Vaginal Antifungals Market Analysis

            14.8.5.1. Introduction

            14.8.5.2. Market Analysis and Forecast By Market Taxonomy

                14.8.5.2.1. By Drug

                14.8.5.2.2. By Route of Administration

                14.8.5.2.3. By Distribution Channel

        14.8.6. BENELUX Vaginal Antifungals Market Analysis

            14.8.6.1. Introduction

            14.8.6.2. Market Analysis and Forecast By Market Taxonomy

                14.8.6.2.1. By Drug

                14.8.6.2.2. By Route of Administration

                14.8.6.2.3. By Distribution Channel

        14.8.7. Russia Vaginal Antifungals Market Analysis

            14.8.7.1. Introduction

            14.8.7.2. Market Analysis and Forecast By Market Taxonomy

                14.8.7.2.1. By Drug

                14.8.7.2.2. By Route of Administration

                14.8.7.2.3. By Distribution Channel

15. East Asia Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Drug

        15.3.3. By Route of Administration

        15.3.4. By Distribution Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Drug

        15.4.3. By Route of Administration

        15.4.4. By Distribution Channel

    15.5. Market Trends

    15.6. Key Market Participants – Intensity Mapping

    15.7. Drivers and Restraints – Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. China Vaginal Antifungals Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast By Market Taxonomy

                15.8.1.2.1. By Drug

                15.8.1.2.2. By Route of Administration

                15.8.1.2.3. By Distribution Channel

        15.8.2. Japan Vaginal Antifungals Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast By Market Taxonomy

                15.8.2.2.1. By Drug

                15.8.2.2.2. By Route of Administration

                15.8.2.2.3. By Distribution Channel

        15.8.3. South Korea Vaginal Antifungals Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast By Market Taxonomy

                15.8.3.2.1. By Drug

                15.8.3.2.2. By Route of Administration

                15.8.3.2.3. By Distribution Channel

16. South Asia Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        16.3.1. By Country

            16.3.1.1. India

            16.3.1.2. Indonesia

            16.3.1.3. Malaysia

            16.3.1.4. Thailand

            16.3.1.5. Rest of South Asia

        16.3.2. By Drug

        16.3.3. By Route of Administration

        16.3.4. By Distribution Channel

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Drug

        16.4.3. By Route of Administration

        16.4.4. By Distribution Channel

    16.5. Market Trends

    16.6. Key Market Participants – Intensity Mapping

    16.7. Drivers and Restraints – Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. India Vaginal Antifungals Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast By Market Taxonomy

                16.8.1.2.1. By Drug

                16.8.1.2.2. By Route of Administration

                16.8.1.2.3. By Distribution Channel

        16.8.2. Indonesia Vaginal Antifungals Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast By Market Taxonomy

                16.8.2.2.1. By Drug

                16.8.2.2.2. By Route of Administration

                16.8.2.2.3. By Distribution Channel

        16.8.3. Malaysia Vaginal Antifungals Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast By Market Taxonomy

                16.8.3.2.1. By Drug

                16.8.3.2.2. By Route of Administration

                16.8.3.2.3. By Distribution Channel

        16.8.4. Thailand Vaginal Antifungals Market Analysis

            16.8.4.1. Introduction

            16.8.4.2. Market Analysis and Forecast By Market Taxonomy

                16.8.4.2.1. By Drug

                16.8.4.2.2. By Route of Administration

                16.8.4.2.3. By Distribution Channel

17. Oceania Vaginal Antifungals Market 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Drug

        17.3.3. By Route of Administration

        17.3.4. By Distribution Channel

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Drug

        17.4.3. By Route of Administration

        17.4.4. By Distribution Channel

    17.5. Key Market Participants – Intensity Mapping

    17.6. Drivers and Restraints – Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. Australia Vaginal Antifungals Market Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast By Market Taxonomy

                17.7.1.2.1. By Drug

                17.7.1.2.2. By Route of Administration

                17.7.1.2.3. By Distribution Channel

        17.7.2. New Zealand Vaginal Antifungals Market Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast By Market Taxonomy

                17.7.2.2.1. By Drug

                17.7.2.2.2. By Route of Administration

                17.7.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Vaginal Antifungals Market Analysis 2017–2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

    18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2022–2032

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Türkiye

            18.3.1.3. South Africa

            18.3.1.4. North Africa

            18.3.1.5. Rest of Middle East and Africa

        18.3.2. By Drug

        18.3.3. By Route of Administration

        18.3.4. By Distribution Channel

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Drug

        18.4.3. By Route of Administration

        18.4.4. By Distribution Channel

    18.5. Market Trends

    18.6. Key Market Participants – Intensity Mapping

    18.7. Drivers and Restraints – Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. GCC Countries Vaginal Antifungals Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast By Market Taxonomy

                18.8.1.2.1. By Drug

                18.8.1.2.2. By Route of Administration

                18.8.1.2.3. By Distribution Channel

        18.8.2. Türkiye Vaginal Antifungals Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast By Market Taxonomy

                18.8.2.2.1. By Drug

                18.8.2.2.2. By Route of Administration

                18.8.2.2.3. By Distribution Channel

        18.8.3. South Africa Vaginal Antifungals Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast By Market Taxonomy

                18.8.3.2.1. By Drug

                18.8.3.2.2. By Route of Administration

                18.8.3.2.3. By Distribution Channel

        18.8.4. North Africa Vaginal Antifungals Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast By Market Taxonomy

                18.8.4.2.1. By Drug

                18.8.4.2.2. By Route of Administration

                18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

    19.1. Market Analysis By Tier of Companies

    19.2. Market Concentration

    19.3. Market Share Analysis of Top Players

    19.4. Market Presence Analysis

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Pfizer Inc.

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Sales Footprint

            20.3.1.4. Key Financials

            20.3.1.5. SWOT Analysis

            20.3.1.6. Strategic Overview

        20.3.2. Bausch Health Companies Inc

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Sales Footprint

            20.3.2.4. Key Financials

            20.3.2.5. SWOT Analysis

            20.3.2.6. Strategic Overview

        20.3.3. ANI Pharmaceuticals, Inc.

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Sales Footprint

            20.3.3.4. Key Financials

            20.3.3.5. SWOT Analysis

            20.3.3.6. Strategic Overview

        20.3.4. Hikma Pharmaceuticals Plc

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Sales Footprint

            20.3.4.4. Key Financials

            20.3.4.5. SWOT Analysis

            20.3.4.6. Strategic Overview

        20.3.5. Lupin Limited

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Sales Footprint

            20.3.5.4. Key Financials

            20.3.5.5. SWOT Analysis

            20.3.5.6. Strategic Overview

        20.3.6. Mycovia Pharmaceuticals, Inc.

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Sales Footprint

            20.3.6.4. Key Financials

            20.3.6.5. SWOT Analysis

            20.3.6.6. Strategic Overview

        20.3.7. Glenmark Pharmaceuticals Limited

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Sales Footprint

            20.3.7.4. Key Financials

            20.3.7.5. SWOT Analysis

            20.3.7.6. Strategic Overview

        20.3.8. Unique Pharmaceuticals

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Sales Footprint

            20.3.8.4. Key Financials

            20.3.8.5. SWOT Analysis

            20.3.8.6. Strategic Overview

        20.3.9. PEPTONIC medical AB

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Sales Footprint

            20.3.9.4. Key Financials

            20.3.9.5. SWOT Analysis

            20.3.9.6. Strategic Overview

        20.3.10. Aurobindo Pharma Limited

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Sales Footprint

            20.3.10.4. Key Financials

            20.3.10.5. SWOT Analysis

            20.3.10.6. Strategic Overview

        20.3.11. Dr. Reddy’s Laboratories

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Sales Footprint

            20.3.11.4. Key Financials

            20.3.11.5. SWOT Analysis

            20.3.11.6. Strategic Overview

        20.3.12. SCYNEXIS, Inc.

            20.3.12.1. Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Sales Footprint

            20.3.12.4. Key Financials

            20.3.12.5. SWOT Analysis

            20.3.12.6. Strategic Overview

        20.3.13. Basilea Pharmaceutica Ltd.

            20.3.13.1. Overview

            20.3.13.2. Product Portfolio

            20.3.13.3. Sales Footprint

            20.3.13.4. Key Financials

            20.3.13.5. SWOT Analysis

            20.3.13.6. Strategic Overview

        20.3.14. Astellas Pharma Inc.

            20.3.14.1. Overview

            20.3.14.2. Product Portfolio

            20.3.14.3. Sales Footprint

            20.3.14.4. Key Financials

            20.3.14.5. SWOT Analysis

            20.3.14.6. Strategic Overview

        20.3.15. Grupo Ferrer Internacional, S.A.

            20.3.15.1. Overview

            20.3.15.2. Product Portfolio

            20.3.15.3. Sales Footprint

            20.3.15.4. Key Financials

            20.3.15.5. SWOT Analysis

            20.3.15.6. Strategic Overview

        20.3.16. Pacgen Life Science Corporation

            20.3.16.1. Overview

            20.3.16.2. Product Portfolio

            20.3.16.3. Sales Footprint

            20.3.16.4. Key Financials

            20.3.16.5. SWOT Analysis

            20.3.16.6. Strategic Overview

        20.3.17. NovaDigm Therapeutics, Inc.

            20.3.17.1. Overview

            20.3.17.2. Product Portfolio

            20.3.17.3. Sales Footprint

            20.3.17.4. Key Financials

            20.3.17.5. SWOT Analysis

            20.3.17.6. Strategic Overview

        20.3.18. Cidara Therapeutics, Inc.

            20.3.18.1. Overview

            20.3.18.2. Product Portfolio

            20.3.18.3. Sales Footprint

            20.3.18.4. Key Financials

            20.3.18.5. SWOT Analysis

            20.3.18.6. Strategic Overview

        20.3.19. Amplyx Pharmaceuticals Inc.

            20.3.19.1. Overview

            20.3.19.2. Product Portfolio

            20.3.19.3. Sales Footprint

            20.3.19.4. Key Financials

            20.3.19.5. SWOT Analysis

            20.3.19.6. Strategic Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Table 01: Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Drug

Table 02: Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration

Table 03: Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel

Table 04: Global Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032, by Region

Table 05: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 06: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug

Table 07: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration

Table 08: North America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel

Table 09: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 10: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug

Table 11: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration

Table 12: Latin America Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel

Table 13: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 14: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug

Table 15: Europe Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration

Table 16: Europe Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel

Table 17: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 18: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug

Table 19: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration

Table 20: East Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel

Table 21: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 22: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug

Table 23: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Route of Administration

Table 24: South Asia Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel

Table 25: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 26: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug

Table 27: Oceania Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration

Table 28: Oceania Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel

Table 29: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 30: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Drug

Table 31: Middle East & Africa Vaginal Antifungals Market Analysis 2012–2021 and Forecast 2022–2032by Route of Administration

Table 32: Middle East & Africa Vaginal Antifungals Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Distribution Channel